Pretzel Therapeutics
PrivateLast Round
VC Round
Jul 11, 2025
Total Funding Raised
$72.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Pretzel Therapeutics is a biotechnology company developing first-in-class therapies to reverse mitochondrial dysfunction by leveraging a deep mechanistic understanding of mitochondrial biology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pretzel Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Pretzel Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jul 11, 2025 | ||||
| Series A | Sep 12, 2022 |
Key People
Founding team and executive leadership
Pretzel Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Vasa Angels I | Series A |
| GV | Series A |
| ARCH Venture Partners | Series A |
| United Mitochondrial Disease Foundation | VC Round |
| HealthCap | Series A |
| Eir Ventures | Series A |
| Invus Opportunities | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 11, 2026
PX578 data presented at the 2026 MDA Clinical & Scientific Conference.
- Mar 11, 2026
Presented data at the 2026 MDA Clinical & Scientific Conference.
Pretzel Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Pretzel Therapeutics's valuation, stock price, and market status.